| 10549379
|
Update on influenza and rhinovirus infections. |
Adv Exp Med Biol |
1999 |
Hayden FG |
View
More |
| 1340735
|
[R-R variability in acute anterior infarct after thrombolytic therapy]. |
Arq Bras Cardiol |
1992 |
Boghossian SH;Maia IG;Costa Filho R;Alves PA |
View
More |
| 23163028
|
[Clinical course of acute respiratory infection and the state of microbiocenosis of upper respiratory tract in pregnant women]. |
Zh Mikrobiol Epidemiol Immunobiol |
2012 |
Kostinov MP;Meshcheriakova AK;Foshina EP;Tarbaeva DA;Savis'ko AA;Zaitseva EV |
View
More |
| 24633687
|
Treatment of persistent rhinovirus infection with pegylated interferon alpha2a and ribavirin in patients with hypogammaglobulinemia. |
Clin Infect Dis |
2014 |
Ruuskanen O;Waris M;Kainulainen L |
View
More |
| 28391633
|
Comparisons of cardioprotective efficacy between fibroblast growth factor 21 and dipeptidyl peptidase-4 inhibitor in prediabetic rats. |
Cardiovasc Ther |
2017 |
Tanajak P;Sa-Nguanmoo P;Apaijai N;Wang X;Liang G;Li X;Jiang C;Chattipakorn SC;Chattipakorn N |
View
More |
| 3011917
|
Intranasal interferon-alpha 2b for seasonal prophylaxis of respiratory infection. |
J Infect Dis |
1986 |
Monto AS;Shope TC;Schwartz SA;Albrecht JK |
View
More |
| 32564036
|
Safety assessment of chronic hepatitis C treatment using h-FABP and 24-hour ECG Holter monitoring. |
Pol Merkur Lekarski |
2020 |
Poliwczak AR;Jedrzejczak-Pospiech K;Blaszczyk J;Bialkowska-Warzecha J;Wozny J;Jabkowski M |
View
More |
| 36909726
|
End-of-treatment anti-HBs levels and HBeAg status identify durability of HBsAg loss after PEG-IFN discontinuation. |
Front Cell Infect Microbiol |
2023 |
Guo Y;Han J;Zhang Y;Jin C;Zhang Y;He J;Chen S;Guo Y;Lin Y;Li F;Yang F;Shen Z;Mao R;Zhu H;Zhang J |
View
More |
